Zhejiang Huahai Pharmaceutical Co.,Ltd. is a multinational enterprise, committed to providing high-quality medical and health products to patients around the world. The company is mainly engaged in the development, production and sales of APIs (Active Pharmaceutical ingredients), intermediates and medical preparations that cover fields such as cardiovascular, psychiatric, anti-virus and anti-histamine. Currently, the company has owned more than 30 subsidiaries and has built long-term cooperative relationships with over 500 pharmaceutical companies around the world. As one of the leading enterprises, Huahai Pharmaceutical is the first pharmaceutical company in China that receives FDA approvals for generic drugs.
